In vitro antifungal activity of hydroxychavicol isolated from Piper betle L

被引:105
|
作者
Ali, Intzar [1 ]
Khan, Farrah G. [3 ]
Suri, Krishan A. [2 ]
Gupta, Bishan D. [2 ]
Satti, Naresh K. [2 ]
Dutt, Prabhu [2 ]
Afrin, Farhat [4 ]
Qazi, Ghulam N. [4 ]
Khan, Inshad A. [1 ]
机构
[1] Indian Inst Integrat Med, Div Clin Microbiol, Jammu 180001, India
[2] Indian Inst Integrat Med, Nat Prod Chem Div, Jammu 180001, India
[3] Acharya Shri Chander Coll Med Sci, Dept Microbiol, Jammu 180017, India
[4] Hamdard Univ, Fac Sci, Dept Biotechnol, New Delhi 110062, India
来源
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS | 2010年 / 9卷
关键词
Minimum Inhibitory Concentration; Propidium Iodide; Antifungal Activity; Candida Species; Terbinafine;
D O I
10.1186/1476-0711-9-7
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: Hydroxychavicol, isolated from the chloroform extraction of the aqueous leaf extract of Piper betle L., (Piperaceae) was investigated for its antifungal activity against 124 strains of selected fungi. The leaves of this plant have been long in use tropical countries for the preparation of traditional herbal remedies. Methods: The minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) of hydroxychavicol were determined by using broth microdilution method following CLSI guidelines. Time kill curve studies, post-antifungal effects and mutation prevention concentrations were determined against Candida species and Aspergillus species "respectively". Hydroxychavicol was also tested for its potential to inhibit and reduce the formation of Candida albicans biofilms. The membrane permeability was measured by the uptake of propidium iodide. Results: Hydroxychavicol exhibited inhibitory effect on fungal species of clinical significance, with the MICs ranging from 15.62 to 500 mu g/ml for yeasts, 125 to 500 mu g/ml for Aspergillus species, and 7.81 to 62.5 mu g/ml for dermatophytes where as the MFCs were found to be similar or two fold greater than the MICs. There was concentration-dependent killing of Candida albicans and Candida glabrata up to 8 x MIC. Hydroxychavicol also exhibited an extended post antifungal effect of 6.25 to 8.70 h at 4 x MIC for Candida species and suppressed the emergence of mutants of the fungal species tested at 2 x to 8 x MIC concentration. Furthermore, it also inhibited the growth of biofilm generated by C. albicans and reduced the preformed biofilms. There was increased uptake of propidium iodide by C. albicans cells when exposed to hydroxychavicol thus indicating that the membrane disruption could be the probable mode of action of hydroxychavicol. Conclusions: The antifungal activity exhibited by this compound warrants its use as an antifungal agent particularly for treating topical infections, as well as gargle mouthwash against oral Candida infections.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Antifungal Activity of Ellagic Acid In Vitro and In Vivo
    Li, Zhi-Jian
    Guo, Xin
    Dawuti, Gulina
    Aibai, Silafu
    PHYTOTHERAPY RESEARCH, 2015, 29 (07) : 1019 - 1025
  • [22] Calendula L. species polyphenolic profile and in vitro antifungal activity
    Faustino, Maria V.
    Pinto, Diana C. G. A.
    Goncalves, Maria Jose
    Salgueiro, Ligia
    Silveira, Paulo
    Silva, Artur M. S.
    JOURNAL OF FUNCTIONAL FOODS, 2018, 45 : 254 - 267
  • [23] ANTIFUNGAL ACTIVITY OF Piper diospyrifolium KUNTH (PIPERACEAE) ESSENTIAL OIL
    Heredia Vieira, Silvia Cristina
    de Paulo, Luis Fernando
    Estivaleti Svidzinski, Terezinha Inez
    Dias Filho, Benedito Prado
    Nakamura, Celso Vataru
    de Souza, Amanda
    Marx Young, Maria Claudia
    Garcia Cortez, Diogenes Aparicio
    BRAZILIAN JOURNAL OF MICROBIOLOGY, 2011, 42 (03) : 1001 - 1005
  • [24] Antibacterial and antifungal activity of extracts and quercetagetin derivate isolated from Centaurea rupestris L. (Asteraceae)
    Rusak, G
    Robinson, N
    Pepeljnjak, S
    ACTA BIOLOGICA CRACOVIENSIA SERIES BOTANICA, 2002, 44 : 169 - 174
  • [25] In vitro ANTIFUNGAL ACTIVITY OF ERYSOVINE
    Ibarra Estrada, Emmanuel
    Tellez Morales, Rocio
    Soto-Hernandez, Marcos
    Martinez Vazquez, Mariano
    Garcia-Mateos, Rosario
    San Miguel-Chavez, Ruben
    REVISTA FITOTECNIA MEXICANA, 2009, 32 (04) : 327 - 330
  • [26] In Vitro Antifungal Activity of Luliconazole, Efinaconazole, and Nine Comparators Against Aspergillus and Candida Strains Isolated from Otomycosis
    Shokoohi, Gholamreza
    Rouhi, Reza
    Etehadnezhad, Mohammad
    Ahmadi, Bahram
    Javidnia, Javad
    Nouripour-Sisakht, Sadegh
    Hooshmand, Farhang
    Rezaei-Matehkolaei, Ali
    Tabatabaeifar, Seyede Nadia
    Ansari, Saham
    JUNDISHAPUR JOURNAL OF MICROBIOLOGY, 2021, 14 (04)
  • [27] In vitro antifungal susceptibility profile of Scopulariopsis brevicaulis isolated from onychomycosis
    Javier Carrillo-Munoz, Alfonso
    Tur-Tur, Cristina
    Cardenes, Delia
    Rojas, Florencia
    Giusiano, Gustavo
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2015, 28 (04) : 210 - 213
  • [28] In vitro antifungal activity of the essential oils from Artemisia spp. L. on Sclerotinia sclerotiorum
    Badea, Monica Luminita
    Delian, Elena
    ROMANIAN BIOTECHNOLOGICAL LETTERS, 2014, 19 (03): : 9345 - 9352
  • [29] In Vitro Susceptibility of Nondermatophyte Molds Isolated from Onycomycosis to Antifungal Drugs
    Trovato, L.
    Rapisarda, M. F.
    Greco, A. M.
    Galata, F.
    Oliveri, S.
    JOURNAL OF CHEMOTHERAPY, 2009, 21 (04) : 403 - 407
  • [30] In Vitro Antifungal Activities against Moulds Isolated from Dermatological Specimens
    Nizam, Tzar Mohd
    Binting, Rabiatul Adawiyah A. G.
    Saari, Shafika Mohd
    Kumar, Thivyananthini Vijaya
    Muhammad, Marianayati
    Satim, Hartini
    Yusoff, Hamidah
    Santhanam, Jacinta
    MALAYSIAN JOURNAL OF MEDICAL SCIENCES, 2016, 23 (03): : 32 - 39